Themis Medicare (BOM:530199) Cyclically Adjusted Revenue per Share: ₹38.61 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530199 Themis Medicare Ltd BOM:530199
69 GF Score
Price ₹104.70
GF Value ₹148.83
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Themis Medicare Cyclically Adjusted Revenue per Share?

Themis Medicare BOM:530199 +0.67% 69 Cyclically Adjusted Revenue per Share is ₹38.61 as of Mar. 2026. GuruFocus rates BOM:530199 with a GF Score™ of 69/100 and a GF Value™ of ₹148.83 (Possible Value Trap). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Themis Medicare's adjusted revenue per share for the three months ended in Mar. 2026 was ₹8.268. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹38.61 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Themis Medicare's average Cyclically Adjusted Revenue Growth Rate was 2.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Themis Medicare was 5.80% per year. The lowest was 4.20% per year. And the median was 5.00% per year.

As of today (2026-08-15), Themis Medicare's current stock price is ₹104.70. Themis Medicare's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ₹38.61. Themis Medicare's Cyclically Adjusted PS Ratio of today is 2.71.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Themis Medicare was 7.82. The lowest was 1.81. And the median was 3.58.


Themis Medicare  (BOM:530199) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Themis Medicare's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=104.70/38.61
=2.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Themis Medicare was 7.82. The lowest was 1.81. And the median was 3.58.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Themis Medicare Cyclically Adjusted Revenue per Share Related Terms


Themis Medicare Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Themis Medicare's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Themis Medicare Cyclically Adjusted Revenue per Share Chart

Themis Medicare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.79 34.08 35.93 37.63 38.61

Themis Medicare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.63 38.25 38.57 38.58 38.61

BOM:530199 vs ZTS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Themis Medicare's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Themis Medicare Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Themis Medicare's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Themis Medicare's Cyclically Adjusted PS Ratio falls into.


BOM:530199
69GF Score
Themis Medicare Ltd BOM:530199
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Themis Medicare Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Themis Medicare's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=8.268/164.2724*164.2724
=8.268

Current CPI (Mar. 2026) = 164.2724.

Themis Medicare Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201603 6.264 102.518 10.037
201606 7.240 105.961 11.224
201609 6.087 105.961 9.437
201612 5.874 105.196 9.173
201703 5.408 105.196 8.445
201709 6.695 109.021 10.088
201712 5.385 109.404 8.086
201803 5.603 109.786 8.384
201806 5.400 111.317 7.969
201809 5.418 115.142 7.730
201812 5.354 115.142 7.639
201903 4.020 118.202 5.587
201906 5.593 120.880 7.601
201909 5.487 123.175 7.318
201912 5.857 126.235 7.622
202003 4.885 124.705 6.435
202006 5.279 127.000 6.828
202009 5.972 130.118 7.540
202012 7.129 130.889 8.947
202103 6.577 131.771 8.199
202106 12.217 134.084 14.968
202109 11.644 135.847 14.080
202112 10.294 138.161 12.240
202203 8.308 138.822 9.831
202206 10.245 142.347 11.823
202209 9.873 144.661 11.211
202212 9.604 145.763 10.824
202303 7.624 146.865 8.528
202306 10.466 150.280 11.440
202309 11.386 151.492 12.347
202312 8.959 152.924 9.624
202403 10.048 153.035 10.786
202406 13.353 155.789 14.080
202409 12.689 157.882 13.203
202412 10.838 158.323 11.245
202503 7.790 157.552 8.122
202506 10.568 159.755 10.867
202509 8.413 162.289 8.516
202512 9.733 163.281 9.792
202603 8.268 164.272 8.268

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹38.61 mean?
Themis Medicare (BOM:530199) has a Cyclically Adjusted Revenue per Share of ₹38.61 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Themis Medicare and its competitors.
Is Themis Medicare's Cyclically Adjusted Revenue per Share too high?
Themis Medicare's current Cyclically Adjusted Revenue per Share is ₹38.61. Overall, Themis Medicare has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Themis Medicare's Cyclically Adjusted Revenue per Share compare to ZTS?
Themis Medicare's Cyclically Adjusted Revenue per Share of ₹38.61 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Themis Medicare and its competitors. Themis Medicare's current Cyclically Adjusted Revenue per Share is ₹38.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Themis Medicare stock overvalued right now?
Based on GuruFocus' analysis, Themis Medicare (BOM:530199) is currently considered Possible Value Trap. The stock's GF Value™ is ₹148.83, compared to a current price of ₹104.70 — trading 29.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹38.61. Themis Medicare's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Themis Medicare (BOM:530199), the current Cyclically Adjusted Revenue per Share is ₹38.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Themis Medicare (BOM:530199) Overvalued in 2026?

Based on GuruFocus' analysis, Themis Medicare stock appears to be undervalued. The current stock price of ₹104.70 is trading 29.7% below its estimated GF Value™ of ₹148.83. GuruFocus considers Themis Medicare to be Possible Value Trap.

Key valuation signals for BOM:530199:

  • Cyclically Adjusted Revenue per Share: ₹38.61
  • GF Value™: ₹148.83 vs. price of ₹104.70 (29.7% below fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the BOM:530199 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Themis Medicare Business Description

Other Exchanges THEMISMED:India
Address Swami Vivekanand Road, 11/12, Udyog Nagar Industrial Estate, Goregaon (West), Mumbai, MH, IND, 400 104
Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. The Company operates only in one business segment which is Pharmaceuticals. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.
69GF Score

Get the complete analysis for BOM:530199

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹104.70
Price
₹148.83
GF Value